Cover Image

Editorial: Adaptive immune resistance in cancer therapy

Saved in:

Bibliographic Details
Main Authors:	Aimin Jiang (Author), Ouyang Chen (Author), Zhigang Liu (Author), Hongzhou Cai (Author), Linhui Wang (Author), Lin Qi (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
by: Aimin Jiang, et al.
Published: (2023)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
by: Xiaoping Lin, et al.
Published: (2022)

Editorial: New strategies for reversing cancer therapy resistance
by: Yue Du, et al.
Published: (2024)

Editorial: Immunity in the development of anti-cancer drug resistance
by: Ya Meng, et al.
Published: (2022)

Editorial: Epigenetic regulation and therapy resistance in cancer
by: Yongxia Zhu, et al.
Published: (2023)

Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment
by: Lingxi Jiang, et al.
Published: (2023)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
by: Xin Zhang, et al.
Published: (2023)

Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy
by: Shengmei Wang, et al.
Published: (2022)

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer
by: Jian Qi, et al.
Published: (2021)

Editorial: Managing cancer metastasis by tackling anticancer drug resistance
by: Erxi Wu, et al.
Published: (2024)

Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
by: Meiqin Li, et al.
Published: (2023)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)

Editorial: Novel biomarkers for anticancer therapy
by: Ting Wang, et al.
Published: (2023)

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
by: Xi Chen, et al.
Published: (2024)

Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma
by: Haiyu Wang, et al.
Published: (2024)

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
by: Qi Cai, et al.
Published: (2022)

Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance
by: Melissa Hui Yen Chng, et al.
Published: (2015)

Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Lijun Da, et al.
Published: (2020)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
by: Wuzhen Chen, et al.
Published: (2021)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
by: Fanfan Zhou, et al.
Published: (2022)

Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer
by: Ziqing Duan, et al.
Published: (2017)

Apical periodontitis promotes insulin resistance and alters adaptive immunity markers in rats
by: Renato Felipe Pereira, et al.
Published: (2021)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024)

Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
by: Lu-Qi Cao, et al.
Published: (2024)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
by: Wenjie Zhao, et al.
Published: (2021)

Education and development of rehabilitation therapy in China under the background of aging
by: Shuyue Sun, et al.
Published: (2022)

The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy
by: Zhuo Wang, et al.
Published: (2021)

Adaptive Immunity and Inflammation
by: Brancaleone Vincenzo, et al.
Published: (2015)

Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
by: Chen Hu, et al.
Published: (2023)

Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children
by: Haiping Ouyang, et al.
Published: (2022)

CircRNA: A new class of targets for gastric cancer drug resistance therapy
by: Ying Zheng, et al.
Published: (2023)

Editorial: Advances in antimicrobial therapy and combating resistance
by: Islam M. Ghazi, et al.
Published: (2023)

Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria
by: Qi Zhang, et al.
Published: (2021)

Hypertension Induced by Combination Therapy of Cancer: A Systematic Review and Meta-Analysis of Global Clinical Trials
by: Xiaodan Guo, et al.
Published: (2021)

Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
by: Céline Pomié, et al.
Published: (2016)

Erratum to "Adaptive Immunity and Inflammation"
by: Vincenzo Brancaleone, et al.
Published: (2015)

Immune-related gene signature improves prognosis prediction in patients with breast cancer and associates it with tumor immunity and inflammatory response
by: Haiping Zhang, et al.
Published: (2024)

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy
by: Yang Yang, et al.
Published: (2022)

Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
by: Jiawei Guan, et al.
Published: (2023)

Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells
by: Yue Han, et al.
Published: (2019)